RADIOPHARMACEUTICAL CAPITAL OF THE WORLD Trademark

Trademark Overview


On Thursday, July 18, 2024, a trademark application was filed for RADIOPHARMACEUTICAL CAPITAL OF THE WORLD with the United States Patent and Trademark Office. The USPTO has given the RADIOPHARMACEUTICAL CAPITAL OF THE WORLD trademark a serial number of 98655204. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 18, 2024. This trademark is owned by Central Indiana Corporate Partnership, Inc.. The RADIOPHARMACEUTICAL CAPITAL OF THE WORLD trademark is filed in the Advertising, Business and Retail Services category with the following description:

Promoting economic development, namely, attracting and creating jobs, companies and entrepreneurial opportunities within Indiana's life science industry
radiopharmaceutical capital of the world

General Information


Serial Number98655204
Word MarkRADIOPHARMACEUTICAL CAPITAL OF THE WORLD
Filing DateThursday, July 18, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, July 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPromoting economic development, namely, attracting and creating jobs, companies and entrepreneurial opportunities within Indiana's life science industry

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, July 18, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCentral Indiana Corporate Partnership, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIndianapolis, IN 46202

Trademark Events


Event DateEvent Description
Thursday, July 18, 2024NEW APPLICATION ENTERED
Friday, July 19, 2024TEAS VOLUNTARY AMENDMENT RECEIVED